Form 8-K - Current report:
SEC Accession No. 0001193125-25-152020
Filing Date
2025-06-30
Accepted
2025-06-30 08:13:38
Documents
13
Period of Report
2025-06-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d163272d8k.htm   iXBRL 8-K 32662
2 EX-99.1 d163272dex991.htm EX-99.1 12108
  Complete submission text file 0001193125-25-152020.txt   155583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20250627.xsd EX-101.SCH 2502
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20250627_lab.xml EX-101.LAB 15919
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20250627_pre.xml EX-101.PRE 9965
15 EXTRACTED XBRL INSTANCE DOCUMENT d163272d8k_htm.xml XML 3341
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 251088823
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)